© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
February 21, 2020
A recent study looking at data from three clinical trials involving Nerlynx shows promise for the future of treating patients with HER-2 positive breast cancer who develop CNS metastases.
Inaccurate Information on Cancer Diagnosis and Treatment Common on Social Media Sites
Small-Town Cancer Team, Big Success
Grief Is Like Swimming
Rick Aiello Dies From Pancreatic Cancer, FDA Approves First Drug to Treat Lymphoma in Dogs and More